GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmena SA (WAR:PHR) » Definitions » Cyclically Adjusted PS Ratio

Pharmena (WAR:PHR) Cyclically Adjusted PS Ratio : (As of Jun. 02, 2025)


View and export this data going back to 2008. Start your Free Trial

What is Pharmena Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Pharmena Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Pharmena's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmena Cyclically Adjusted PS Ratio Chart

Pharmena Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 4.71 2.81 3.56

Pharmena Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.56 4.28 3.13 3.00 -

Competitive Comparison of Pharmena's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Pharmena's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmena's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmena's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Pharmena's Cyclically Adjusted PS Ratio falls into.


;
;

Pharmena Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Pharmena's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Pharmena's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.035/157.0208*157.0208
=0.035

Current CPI (Mar. 2025) = 157.0208.

Pharmena Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 0.438 100.041 0.687
201506 0.414 100.448 0.647
201509 0.512 99.634 0.807
201512 0.533 99.471 0.841
201603 0.269 98.983 0.427
201606 0.450 99.552 0.710
201609 0.486 99.064 0.770
201612 0.523 100.366 0.818
201703 0.292 101.018 0.454
201706 0.382 101.180 0.593
201709 0.313 101.343 0.485
201712 0.369 102.564 0.565
201803 0.420 102.564 0.643
201806 0.310 103.378 0.471
201809 0.385 103.378 0.585
201812 0.367 103.785 0.555
201903 0.365 104.274 0.550
201906 0.228 105.983 0.338
201909 0.307 105.983 0.455
201912 0.218 107.123 0.320
202003 0.231 109.076 0.333
202006 0.167 109.402 0.240
202009 0.274 109.320 0.394
202012 0.231 109.565 0.331
202103 0.296 112.658 0.413
202106 0.313 113.960 0.431
202109 0.359 115.588 0.488
202112 0.398 119.088 0.525
202203 0.326 125.031 0.409
202206 -0.311 131.705 -0.371
202209 0.000 135.531 0.000
202212 1.694 139.113 1.912
202303 0.014 145.950 0.015
202306 0.001 147.009 0.001
202309 0.000 146.113 0.000
202312 0.868 147.741 0.923
202403 0.001 149.044 0.001
202406 0.013 150.997 0.014
202409 0.002 153.439 0.002
202503 0.035 157.021 0.035

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pharmena  (WAR:PHR) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Pharmena Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Pharmena's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmena Business Description

Industry
Traded in Other Exchanges
N/A
Address
Ulica Wolczanska 178, Lodz, POL, 90-530
Pharmena SA produces cosmeceuticals and pharmaceuticals. The company's activity focuses on three areas such as research in the USA and Canada on the application of selected pyridinium salts in medicine in order to develop an anti-atherosclerosis drug on a global scale, Production and sales of innovative patented dermocosmetics and introduction into the market of an innovative dietary supplement for atherosclerosis prophylaxis. Its products include Menavitin, Dermena, Allerco and Thermi.